Dymista

Dymista

Manufacturer:

Viatris

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Per actuation Azelastine HCl 137 mcg, fluticasone propionate 50 mcg
Indications/Uses
Symptomatic relief of moderate to severe seasonal allergic rhinitis in adult & childn >6 yr, & perennial allergic rhinitis in adult & childn >12 yr if the use of intranasal antihistamine or corticosteroid alone is not sufficient.
Dosage/Direction for Use
Adult & adolescents (childn ≥6 yr) 1 spray into each nostril in the morning & evening.
Contraindications
Special Precautions
Patients w/ untreated TB, bacterial, fungal & viral infection. History of increased ocular pressure, glaucoma &/or cataracts. Prolonged use may cause slow growth in childn & adolescents. Benzalkonium Cl content may cause nasal mucosa irritation & bronchospasm. Not recommended for childn <6 yr.
Adverse Reactions
Azelastine HCl: Bitter taste, somnolence. Fluticasone propionate: Mild or transient burning, dryness, irritation inside the nose.
Drug Interactions
Plasma conc may be affected by strong CYP3A4 inhibitors eg, ritonavir, ketoconazole.
MIMS Class
Nasal Decongestants & Other Nasal Preparations
ATC Classification
R01AD58 - fluticasone, combinations ; Belongs to the class of topical corticosteroids used for prophylaxis and treatment of allergic rhinitis.
Presentation/Packing
Form
Dymista nasal spray
Packing/Price
25 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in